TABLE 4 ] .
θ During Quiet Breathing | θRC, ° | θRC Treated (or Worst Affected) Side, ° | θRC Untreated Side, ° | |||||||||
Pre | Post | Change | P Valuea | Pre | Post | Change | P Value | Pre | Post | Change | P Valuea | |
LVRS | 28.2 ± 31.5 | 11.0 ± 19.1 | –17.3 ± 40.5 | .10 | 36.2 ± 33.8 | 10.8 ± 19.3 | –25.4 ± 42.5 | .13 | 24.0 ± 30.6 | 12.1 ± 21.6 | –11.9 ± 41.1 | .43 |
BLVR | 50.1 ± 42.2 | 7.7 ± 17.1 | –42.4 ± 30.3 | .02 | 51.6 ± 47.4 | 2.0 ± 14.0 | –49.6 ± 36.2 | .02 | 46.1 ± 35.7 | 20.8 ± 35.5 | –25.3 ± 47.0 | .22 |
All LVR | 37.8 ± 37.0 | 9.5 ± 17.8 | –28.2 ± 37.5 | .004 | 42.9 ± 39.6 | 6.9 ± 17.2 | –36.0 ± 40.5 | .005 | 33.6 ± 33.7 | 15.9 ± 27.8 | –14.7 ± 42.8 | .10 |
Control subjects | 20.9 ± 40.3 | 36.9 ± 37.5 | 16.1 ± 45.1 | .16 | 20.2 ± 38.2 | 38.0 ± 36.5 | 17.8 ± 38.1 | .16 | 23.1 ± 43.6 | 35.4 ± 40.2 | 12.3 ± 54.9 | .77 |